Invention Grant
- Patent Title: 1-methyl-1H-pyrazol-3-yl derivatives for use in the treatment of neovascular diseases
-
Application No.: US17817136Application Date: 2022-08-03
-
Publication No.: US12024504B2Publication Date: 2024-07-02
- Inventor: Andrew Douglas Baxter , Jonathan Morris
- Applicant: EXONATE LIMITED
- Applicant Address: GB Duxford
- Assignee: EXONATE LIMITED
- Current Assignee: EXONATE LIMITED
- Current Assignee Address: GB Cambridge
- Agency: Berg Hill Greenleaf Ruscitti LLP
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61P27/02 ; C07D405/14
Abstract:
Anti-angiogenic treatments and compounds for use in anti-angiogenic treatments, particularly of conditions associated with abnormal angiogenesis or abnormal over-production of pro-angiogenic VEGFxxx isoforms in or on the eye are described.
Public/Granted literature
- US20220411412A1 1-METHYL-1H-PYRAZOL-3-YL DERIVATIVES FOR USE IN THE TREATMENT OF NEOVASCULAR DISEASES Public/Granted day:2022-12-29
Information query
